Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection
Ya‐Ting Chang, Chih‐Ching Wu, Yi‐Ming Shyr, et al.
PLoS ONE (2011) Vol. 6, Iss. 5, pp. e20029-e20029
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Recognition of Tumors by the Innate Immune System and Natural Killer Cells
Assaf Marcus, Benjamin G. Gowen, Thornton W. Thompson, et al.
Advances in immunology (2014), pp. 91-128
Open Access | Times Cited: 346
Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
Guranda Chitadze, Jaydeep Bhat, Marcus Lettau, et al.
Scandinavian Journal of Immunology (2013) Vol. 78, Iss. 2, pp. 120-129
Open Access | Times Cited: 169
Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
Andrea Gras Navarro, Andreas T. Björklund, Martha Chekenya
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 151
NKG2D signaling in cancer immunosurveillance
Alejandro López‐Soto, Leticía Huergo-Zapico, Andrea Acebes‐Huerta, et al.
International Journal of Cancer (2014) Vol. 136, Iss. 8, pp. 1741-1750
Open Access | Times Cited: 128
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
Robert O’Neill, Alina Stoita
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4045-4087
Open Access | Times Cited: 77
Global secretome analysis identifies novel mediators of bone metastasis
Mario Andrés Blanco, Gary LeRoy, Zia Khan, et al.
Cell Research (2012) Vol. 22, Iss. 9, pp. 1339-1355
Open Access | Times Cited: 91
Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
Iole Maria Di Gangi, Tommaso Mazza, Andrea Fontana, et al.
Oncotarget (2015) Vol. 7, Iss. 5, pp. 5815-5829
Open Access | Times Cited: 78
The Paradoxical Role of NKG2D in Cancer Immunity
Sam Sheppard, Amir Ferry, Joana Guedes, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 60
Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness
Mathilde Cadoux, Stefano Caruso, Sandrine Pham, et al.
Journal of Hepatology (2021) Vol. 74, Iss. 6, pp. 1386-1397
Open Access | Times Cited: 49
Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis
Lei Jin, Yan Zhang, Hui Li, et al.
Cell Research (2012) Vol. 22, Iss. 9, pp. 1356-1373
Open Access | Times Cited: 60
Strategies for discovering novel pancreatic cancer biomarkers
Alison Chan, Eleftherios P. Diamandis, Ivan M. Blasutig
Journal of Proteomics (2012) Vol. 81, pp. 126-134
Open Access | Times Cited: 59
Secretome Profiling of Primary Cells Reveals That THBS2 Is a Salivary Biomarker of Oral Cavity Squamous Cell Carcinoma
Chia‐Wei Hsu, Jau‐Song Yu, Pei-Hua Peng, et al.
Journal of Proteome Research (2014) Vol. 13, Iss. 11, pp. 4796-4807
Closed Access | Times Cited: 57
Identification of Human Complement Factor B as a Novel Biomarker Candidate for Pancreatic Ductal Adenocarcinoma
Min Jung Lee, Keun Na, Seul‐Ki Jeong, et al.
Journal of Proteome Research (2014) Vol. 13, Iss. 11, pp. 4878-4888
Closed Access | Times Cited: 55
Identification of salivary autoantibodies as biomarkers of oral cancer with immunoglobulin A enrichment combined with affinity mass spectrometry
Hao‐Wei Chu, Kai‐Ping Chang, Wei‐Chen Yen, et al.
PROTEOMICS (2023) Vol. 23, Iss. 9
Closed Access | Times Cited: 16
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
Neil J. Shimwell, Richard T. Bryan, Wenbin Wei, et al.
British Journal of Cancer (2013) Vol. 108, Iss. 9, pp. 1854-1861
Open Access | Times Cited: 51
Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects
Hye‐Nam Son, Ju-Ock Nam, Soyoun Kim, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2013) Vol. 1833, Iss. 10, pp. 2378-2388
Closed Access | Times Cited: 49
Proteomic approaches to decipher cancer cell secretome
Jessica Brandi, Marcello Manfredi, Giulia Speziali, et al.
Seminars in Cell and Developmental Biology (2017) Vol. 78, pp. 93-101
Closed Access | Times Cited: 46
High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
Thilde Terkelsen, Maria Pernemalm, Pavel Gromov, et al.
Molecular Oncology (2020) Vol. 15, Iss. 2, pp. 429-461
Open Access | Times Cited: 36
In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
Lucía Fernández, Raquel Portugal, Jaime Valentín, et al.
Frontiers in Oncology (2013) Vol. 3
Open Access | Times Cited: 43
Natural killer cells can exert a graft-vs-tumor effect in haploidentical stem cell transplantation for pediatric solid tumors
Antonio Pérez‐Martínez, Inmaculada de Prada Vicente, Lucía Fernández, et al.
Experimental Hematology (2012) Vol. 40, Iss. 11, pp. 882-891.e1
Open Access | Times Cited: 43
Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma
Hsin‐Pai Li, Hsin‐Yi Huang, Yi-Ru Lai, et al.
Oncotarget (2014) Vol. 5, Iss. 17, pp. 7610-7624
Open Access | Times Cited: 40
Molecular markers in pancreatic cancer diagnosis
Marta Herreros‐Villanueva, Meritxell Gironella, Antoni Castells, et al.
Clinica Chimica Acta (2013) Vol. 418, pp. 22-29
Closed Access | Times Cited: 40
An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma
Grasieli de Oliveira, Paula Paccielli Freire, Sarah Santiloni Cury, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 716-716
Open Access | Times Cited: 28
MICA/B-targeted antibody promotes NK cell–driven tumor immunity in patients with intrahepatic cholangiocarcinoma
Barbara Oliviero, Stefania Varchetta, Dalila Mele, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 17
RNA biosensors for detection of pancreatic cancer
Mohammad-Jalil Zare-Mehrjardi, Mahtab Hatami-Araghi, Majid Jafari‐Khorchani, et al.
Clinica Chimica Acta (2025) Vol. 571, pp. 120237-120237
Closed Access
Page 1 - Next Page

Scroll to top